In rebuttal to Pharmaniaga, MoH says third Sinovac dose less effective against Covid-19 than different brand booster | Malaysia
KUALA LUMPUR, Feb 10 — A heterologous booster (Sinovac primary vaccination, followed by a Pfizer booster) offers greater protection against infection than a homologous booster dose (three doses of Sinovac) among Sinovac recipients, according to the Institute for Clinical Research (ICR), Ministry...
Kuala Lumpur Hong Kong Pharmaniaga Berhad Shafwan Zaidon Institute For Clinical Research Malaysian National Covid
Source: malaymail.com